← Corporate Investment

Corporate Investment supply-chain observations

Dated, source-backed observations. A reported relationship is not an open purchase order. Verify the original disclosure before acting.

Palantir raises FY26 revenue guidance after 96% third-quarter growth

Cummins Q3 Preview: Consensus Sees EPS of $8.38 on $9.9 Billion Revenue

Shopify shares plunge after revenue miss; Wells Fargo flags AI-related margin pressure

AppLovin’s earnings test shifts from growth to revisions

Walmart Extends Shopper Data Into Vibe’s CTV Platform

Walmart Audiences in Vibe’s campaign builder

Chain role: enabling · Actor: Walmart Connect

Reported operations — not an open tender · Qualified inference

Walmart made its first-party audiences available inside Vibe for CTV campaigns, with Walmart Connect building and maintaining the audiences and Vibe handling campaign buying, optimization, measurement and reporting.

Disclosed scope: category purchases, life stages, lifestyle interests, seasonal moments and shopping habits, alongside advertisers’ own customer data

Retail shopping behavior and customer data support CTV campaign targeting and measurement.

Verify next: Subsequent disclosure of advertiser adoption, campaign outcomes and incremental results.

Risk: The reviewed reporting does not quantify advertiser uptake, campaign performance or incremental spending.

Observed

Source publication:

Source: exchangewire.com

Read analysis and sources →

Williams reports Q3 adjusted EPS below consensus as revenue beats estimates

Enbridge Set to Report Q3 2026 Results on Nov. 6

Sandisk’s overseas growth carries uneven execution risk

Caterpillar Brings Midwestern Fabick Network In-House

Quanta’s record backlog strengthens the infrastructure demand case

Electric infrastructure activity

Reported operations — not an open tender · Disclosed project pipeline

Electric infrastructure activity helped drive Quanta Services’ third-quarter results; total backlog reached a record $63.7 billion and remaining performance obligations totaled $41.8 billion.

Electric infrastructure work supported third-quarter results, accompanied by record total backlog and $41.8 billion of remaining performance obligations.

Verify next: A later Quanta disclosure of changes in total backlog and remaining performance obligations.

Risk: The reviewed report does not identify backlog mix, customers, project timing or an open procurement process.

Observed

Source publication:

Source: Danessa Lincoln

Read analysis and sources →

Freeport-McMoRan Earnings Set Higher Copper Sales Outlook

Amgen earnings preview: MariTide scrutiny and revenue estimates

India’s GST growth strengthens, led by import receipts

AbbVie’s growth engines outpace Humira erosion

Gilead raises sales outlook as acquired R&D deepens 2026 loss

Biktarvy

Reported operations — not an open tender · Disclosed fact

Biktarvy generated $4.1 billion in third-quarter 2026 sales and reached 53% US treatment market share.

Commercial HIV treatment product with reported US market share.

Verify next: Subsequent Biktarvy sales, market-share and Medicare pricing disclosures

Risk: A completed Medicare price determination is expected to affect revenue in 2028.

Observed

Source publication:

Source: allinvestview.com

Read analysis and sources →

Yeztugo and Descovy for PrEP

Reported operations — not an open tender · Disclosed fact

The products jointly held 50% market share and a $4 billion annual run rate, according to management.

Existing HIV-prevention portfolio with reported sales scale and market share.

Verify next: Subsequent PrEP sales and market-share disclosure

Risk: Annual run rate does not itself establish future sales or procurement demand.

Observed

Source publication:

Source: allinvestview.com

Read analysis and sources →

Trodelvy

Reported operations — not an open tender · Disclosed fact

Trodelvy sales grew 42% year over year to an approximately $2 billion annual run rate in third-quarter 2026.

Existing oncology product generated reported sales growth.

Verify next: Subsequent Trodelvy sales disclosure

Risk: The reviewed coverage does not quantify the effect of an approximately $2 billion annual run rate on reported quarterly revenue.

Observed

Source publication:

Source: allinvestview.com

Read analysis and sources →

Livdelzi

Reported operations — not an open tender · Disclosed fact

Livdelzi contributed to third-quarter 2026 base-business growth.

Newer product contributed to reported base-business growth.

Verify next: Subsequent disclosure of Livdelzi sales and contribution

Risk: The reviewed coverage does not disclose product-level revenue or launch timing.

Observed

Source publication:

Source: simplywall.st

Read analysis and sources →

Novartis holds rating as Q3 2026 balances near-term pressure with pipeline hope

A $1,000 KKR Investment Would Be Worth $6,603.72 After 10 Years

Quanta Services’ record backlog signals durable power demand

Altria’s raised outlook shows pricing still outruns cigarette volume declines

Marlboro

Chain role: downstream

Reported operations — not an open tender · Disclosed fact

Marlboro expanded its share of the premium cigarette segment to 60%, up 0.3 percentage point year over year and 0.4 point sequentially.

Premium-segment share and pricing realization support smokable-products earnings despite declining cigarette volumes.

Verify next: Subsequent disclosure of Marlboro premium-segment share, pricing realization and domestic cigarette volume.

Risk: Continued migration toward discount brands could weaken overall retail share and premium mix.

Observed

Source publication:

Source: Don Miller

Read analysis and sources →

Cowboy Cut

Reported operations — not an open tender · Disclosed fact

Cowboy Cut was available in about 100,000 stores, representing roughly 75% of cigarette volume, and was intended to provide value-sensitive smokers with a premium Marlboro option.

A premium-value offer may retain smokers within the Marlboro franchise as consumers move toward discount brands.

Verify next: Subsequent disclosure of retail availability, Marlboro retail share and value-segment performance.

Risk: Price-sensitive consumers may continue trading down despite the broader Marlboro offering.

Observed

Source publication:

Source: Don Miller

Read analysis and sources →

on! nicotine pouches

Chain role: downstream

Reported operations — not an open tender · Disclosed fact

Helix’s reported on! shipment volume increased 13.3% to 47.8 million cans in the third quarter, while year-to-date shipments rose 7.7%.

Product expansion and distribution support shipment growth within the oral-tobacco category.

Verify next: Subsequent disclosure of shipment volume and on! retail share.

Risk: Quarterly retail share declined sequentially despite shipment growth, indicating potential channel or competitive pressure.

Observed

Source publication:

Source: Don Miller

Read analysis and sources →

Applied Materials Draws Buy Rating at About 23x Forward Earnings Ahead of Fiscal Q4 Report